Treatment with IMM-101 induces protective CD8+ T cell responses in clinically relevant models of pancreatic cancer.

Pancreatic cancer is an aggressive cancer with poor prognosis. Despite its low incidence, it is the 4th cause of cancer-related death in the US.

Journal: Journal of ImmunoTherapy of Cancer
Author[s]: Androulla Elia, Louise Lincoln, Laura Rosa Brunet and Thorsten Hagemann

Date: 7 November 2013

DOI: 10.1186/2051-1426-1-S1-P215

View poster presented at SITC 2013